So, I speculate that tomorrow's column will deal with the Merck/J&J deal?
Do you happen to know if there are any investigations into using the J&J virus-vector vaccine as a nasal spray? The vector is a cold virus, it should readily infect the upper respiratory tract, and this might provide increased protection against infection (as opposed to symptomatic infection).
So, I speculate that tomorrow's column will deal with the Merck/J&J deal?
Do you happen to know if there are any investigations into using the J&J virus-vector vaccine as a nasal spray? The vector is a cold virus, it should readily infect the upper respiratory tract, and this might provide increased protection against infection (as opposed to symptomatic infection).